Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HUMANA INC Director's Dealing 2024

Jan 3, 2024

30145_dirs_2024-01-03_8119fa2b-436a-4ed5-a69c-0add418649bb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HUMANA INC (HUM)
CIK: 0000049071
Period of Report: 2024-01-02

Reporting Person: DAMELIO FRANK A (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-01-02 Restricted Stock Units $ A 430 Acquired Humana Common (430) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Humana Common 20634 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Restricted Stock Units $ Humana Common (24847) 24847 Direct
Restricted Stock Units $ Humana Common (2467) 2467 Direct
Restricted Stock Units $ Humana Common (318) 318 Direct

Footnotes

F1: Annual Director's fee payable in stock units which have been deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2: Director's cash fee elected to be converted into stock units, deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis (over a five-year period), exempt pursuant to Rule 16(b)-3(d)(1).

F3: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F4: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/24.

F5: Previously reported direct shares were transferred into 2023 GRAT 1 on 1/17/2023. All shares are held indirectly in 3 separate Grantor Retained Annuity Trusts where reporting person is the sole Trustee.